Systemic lupus erythematosus presenting with pseudotumor cerebri: A rare association

Turkish Journal of Pediatrics

Volumn 49, Issue 1, 2007, Pages 98-101

  Kuyucu, Semanur ^a   Argin, Atila ^a   Kuyucu, Necdet ^a   Özen, Seza ^b  

^a MERSIN UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anticardiolipin antibodies; Azathioprine; Corticosteroids; Idiopathic intracranial hypertension; Pseudotumor cerebri; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN PSEUDOTUMOR; CASE REPORT; COOMBS POSITIVE HEMOLYTIC ANEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEADACHE; HOSPITAL ADMISSION; HUMAN; INTRACRANIAL PRESSURE; LOW DRUG DOSE; LYMPHOCYTOPENIA; NEUROIMAGING; PHLEBOGRAPHY; POLYARTHRITIS; REMISSION; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM;

ADOLESCENT; ANTIMETABOLITES; AZATHIOPRINE; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; PSEUDOTUMOR CEREBRI;

EID: 34247100314     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Quintero-Del-Rio AI, Miller V. Neurologic symptoms in children with systemic lupus erythematosus. J Child Neurol 2000; 15: 803-807.
2. Wall M. Idiopathic intracranial hypertension. Neurol Clin 1991; 9: 73-95.
3. Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002; 17: 745-748.
4. Bettman JW, Daroff RB, Sanders MD, Joyt WF. Papilledema and asymptomatic intracranial hypertension in systemic lupus erythematosus. A fluorescein angiographic study of resolving papilledema. Arch Ophthalmol 1968; 80: 189-193.
5. Green L, Vinker S, Amital H, et al. Pseudotumor cerebri in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25: 103-108.
6. Sbeiti S, Kayed DM, Majuri H. Pseudotumor cerebri presentation of systemic lupus erythematosus: more than an association. Rheumatology (Oxford) 2003; 42: 808-810.
7. Padeh S, Passwell JH. Systemic lupus erythematosus presenting as idiopathic intracranial hypertension. J Rheumatol 1996; 23: 1266-1268.
8. Ahlskog JE, O'Neill BP. Pseudotumor cerebri. Ann Intern Med 1982; 97: 249-256.
9. Scott IU, Siatkowski FM, Eneyni M, Brodsky MC, Lam BL. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997; 124: 253-255.
10. Dhiravibulya KL, Ouvrier R, Johston I, Procopis P, Anthony J. Benign intracranial hypertension in childhood: a review of 23 patients. J Paediatr Child Health 1991; 27: 304-307.
11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
12. Yoo WH, Park JH, Kim HK, Park TS, Baek HS. Recurrent pseudotumor cerebri in systemic lupus erythematosus: a case report. J Korean Med Sci 2001; 16: 805-808.
13. Horoshovski D, Amital H, Katz M, Shoenfeld Y. Pseudotumor cerebri in SLE. Clin Rheumatol 1995; 14: 708-710.
14. DelGiudice GC, Scher CA, Athreye BD, Diamond GR. Pseudotumor cerebri and childhood systemic lupus erythematosus. J Rheum 1986; 13: 748-752.
15. Parnass SM, Goodwin JA, Patel DV, Levinson DJ, Reinhard JD. Dural sinus thrombosis: a mechanism for pseudotumor cerebri in systemic lupus erythematosus. J Rheumatol 1987; 14: 152-155.
16. Alarcon-Segovia D, Estanol B, Garcia-Ramos G, Villa AR. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus. Ann N Y Acad Sci 1997; 823: 279-288.
17. Kesler A, Ellis MH, Reshef T, Kott E, Gadoth N. Idiopathic intracranial hypertension and anticardiolipin antibodies. J Neurol Neurosurg Psychiatry 2000; 68: 379-380.
18. Triplett DA. Antiphospholipid protein antibody: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31.
19. Lockskin MD. Antiphospholipid antibody syndrome. In: Ruddy S, Harris ED, Sledge CB (eds). Kelley's Textbook of Rheumatology (6th ed). New York: WB Saunders Company, 2001: 1145.
20. Alarcon-Segovia D, Boffa MC, Branch W, et al. Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 2003; 12: 499-503.